Clinical Trial Update: Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing

View source ↗

Summary

An ongoing Beijing-based clinical trial evaluating an AI-based early warning system to screen for prostate and bladder cancer in men, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Prostate Cancer

Snippet

Sponsor: Peking University First Hospital | Conditions: Prostate Cancer, Community-based Screening | Status: RECRUITING